• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Real-Time CGM With Predictive Alarm Improves Glycemic Control in T1D

News
Article

A study of adolescents with type 1 diabetes (T1D) found that real-time continuous glucose monitoring (CGM) with a predictive hypoglycemia alarm reduced the time spent below range.

The use of real-time continuous glucose monitoring (RT-CGM) with a predictive alarm for hypoglycemia significantly reduced the risk of hypoglycemic events among adolescents with type 1 diabetes (T1D), according to a study published in Diabetes, Obesity, and Metabolism.

RT-CGM devices have become a widely used tool for the management of diabetes in recent years, especially in children and young people with T1D, the authors noted. They have become the standard in glycometabolic control, including among those managing diabetes with multiple daily insulin injections (MDI), and they allow for the analysis of extensive data on current glucose levels to help with therapy decisions.

When used in tandem with an insulin pump, RT-CGM can improve and maintain glycemic control via an integrated system; the gold standard for patients not using an insulin pump is still intensified basal-bolus MDI. However, the authors explained that the latter management protocol can elevate the risk of hypoglycemic events. Predictive alarm technology offers a potential solution to improve management in these patients by making them aware of glycemic trends and influencing therapeutic habits.

Glucose monitor | Image credit: romaset - stock.adobe.com

Glucose monitor | Image credit: romaset - stock.adobe.com

The crossover, monocentric, randomized study evaluated the efficacy of RT-CGM with predictive alarm technology in a group of 20 adolescents with T1D based on time below range over 8 weeks, including a run-in period, a pair of 2-week treatment periods—1 period with a predictive alarm 20 minutes prior to a 70 mg/dl threshold and 1 period with an alarm on threshold (AoT) at 70mg/dl—and a 2-week washout period. Ten patients were randomized to first use AoT then a predictive alarm, and 10 first used the predictive alarm followed by the AoT. Hypoglycemia was defined as less than 70 mg/dl, and severe hypoglycemia was defined as <54 mg/dl.

When participants were using the predictive alarm, they spent less time in hypoglycemia and severe hypoglycemia. With the predictive alarm, there was a reduction of more than 40% in time spent below range in hypoglycemia and more than 60% in time spent in severe hypoglycemia. The percentage of time below range in hypoglycemia with the predictive alarm was 1.68 vs 2.90 with the AoT (P < .02) and the percentages of time spent below range in severe hypoglycemia were 0.32 and 0.91, respectively (P < .02).

There was also a lower number of hypoglycemic events when the predictive alarm was used (0.65% vs 5.8%; P ≤ .01). Fewer grams of simple sugar for correction were consumed with use of the predictive alarm, as well (30.1 vs 125.5; P < .01). There was also an improvement in glucose control in terms of hyperglycemia and glycemic variability, the authors noted.

The study’s main limitation was the small number of participants, as well as the inclusion of adolescents only, limiting its generalizability. However, the authors noted that the adolescent group is one of the most notoriously difficult to treat, potentially making the inclusion of adolescents only a strength.

“In our study, we showed how the use of the predictive technology for hypoglycemia could help to reduce the risk of having a hypoglycemic event with the predictive alarm set at 20 minutes before, reducing the burden because of the frequency of CGM alarms,” the authors wrote. “With the used predictive alarm setting (a relatively short time before the hypoglycemic event), the system was able to alert participants in time, to avoid hypoglycemia, as shown by the significant reduction of numbers of hypoglycemic events recorded.”

Reference

Marigliano M, Piona C, Mancioppi V, Morotti E, Morandi A, Maffeis C. Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes. Diabetes Obes Metab. Published online January 4, 2024. doi:10.1111/dom.15432

Related Videos
Dr Chris Pagnani
Screenshot of Ryan Nix, PharmD, during a video interview
Screenshot of Fran Gregory, PharmD, MBA, during a video interview
Video 13 - "Individualized Therapy for Specific Infections Associated with Bronchiectasis"
Screenshot of Christie Smith, PharmD, MBA, during a video interview
Michael Morse, MD, Duke University Cancer Center
Amit Singal, MD, UT Southwestern Medical Center
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Beau Raymond, MD
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.